FDA — authorised 7 April 1960
- Application: NDA012283
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: HYGROTON
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Chlorthalidone with potassium chloride in United States
FDA authorised Chlorthalidone with potassium chloride on 7 April 1960
Marketing authorisation
Other Cardiovascular approved in United States
Frequently asked questions
Is Chlorthalidone with potassium chloride approved in United States?
Yes. FDA authorised it on 7 April 1960.
Who is the marketing authorisation holder for Chlorthalidone with potassium chloride in United States?
SANOFI AVENTIS US holds the US marketing authorisation.